• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能损害对脑脊液中游离κ轻链的影响。

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid.

作者信息

Konen Franz F, Schwenkenbecher Philipp, Wurster Ulrich, Jendretzky Konstantin F, Möhn Nora, Gingele Stefan, Sühs Kurt-Wolfram, Hannich Malte J, Grothe Matthias, Witte Torsten, Stangel Martin, Süße Marie, Skripuletz Thomas

机构信息

Department of Neurology, Hannover Medical School, Hannover, Germany.

Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.

出版信息

J Cent Nerv Syst Dis. 2021 Nov 19;13:11795735211042166. doi: 10.1177/11795735211042166. eCollection 2021.

DOI:10.1177/11795735211042166
PMID:34840504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619759/
Abstract

BACKGROUND

The determination of kappa free light chains (KFLC) in cerebrospinal fluid (CSF) is an upcoming biomarker for the detection of an intrathecal immunoglobulin synthesis. Since renal function impairment leads to altered serum KFLC and albumin concentrations, interpretation of KFLC in CSF may be influenced by these parameters.

METHODS

In this two-center study, the influence of renal function (according to the CKD-EPI creatinine equation) on KFLC and albumin concentrations was investigated in patients with "physiological" (n = 139), "non-inflammatory" (n = 146), and "inflammatory" (n = 172) CSF profiles in respect to the KFLC index and the evaluation in quotient diagrams in reference to the hyperbolic reference range (KFLC IF).

RESULTS

All sample groups displayed declining KFLC indices and KFLC IF values with decreasing renal function (-values between <.0001 and .0209). In "inflammatory" CSF profile samples, 15% of the patients presented a KFLC index <5.9 while 10% showed an intrathecal KFLC fraction below Q(lim), suggesting possible false negative KFLC results.

CONCLUSIONS

The influence of renal function should be considered while interpreting KFLC results in patients with neuroinflammatory diseases. The interpretation of KFLC in quotient diagrams is less susceptible to renal function impairment than the KFLC index and should be preferentially used.

摘要

背景

脑脊液(CSF)中游离κ轻链(KFLC)的测定是一种用于检测鞘内免疫球蛋白合成的新兴生物标志物。由于肾功能损害会导致血清KFLC和白蛋白浓度发生变化,脑脊液中KFLC的解读可能会受到这些参数的影响。

方法

在这项双中心研究中,针对“生理性”(n = 139)、“非炎性”(n = 146)和“炎性”(n = 172)脑脊液谱的患者,根据CKD-EPI肌酐方程研究肾功能对KFLC和白蛋白浓度的影响,涉及KFLC指数以及参照双曲线参考范围(KFLC IF)在商图中的评估。

结果

所有样本组的KFLC指数和KFLC IF值均随肾功能下降而降低(P值在<.0001至.0209之间)。在“炎性”脑脊液谱样本中,15%的患者KFLC指数<5.9,而10%的患者鞘内KFLC分数低于Q(lim),提示可能出现KFLC结果假阴性。

结论

在解读神经炎性疾病患者的KFLC结果时应考虑肾功能的影响。与KFLC指数相比,商图中KFLC的解读受肾功能损害的影响较小,应优先使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/dec78f3b8bf3/10.1177_11795735211042166-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/3c992b693b55/10.1177_11795735211042166-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/7b6fe92fc651/10.1177_11795735211042166-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/dec78f3b8bf3/10.1177_11795735211042166-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/3c992b693b55/10.1177_11795735211042166-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/7b6fe92fc651/10.1177_11795735211042166-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8989/8619759/dec78f3b8bf3/10.1177_11795735211042166-fig3.jpg

相似文献

1
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid.肾功能损害对脑脊液中游离κ轻链的影响。
J Cent Nerv Syst Dis. 2021 Nov 19;13:11795735211042166. doi: 10.1177/11795735211042166. eCollection 2021.
2
Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?游离κ轻链的赖伯图:评估鞘内合成的新标准?
Diagnostics (Basel). 2019 Nov 16;9(4):194. doi: 10.3390/diagnostics9040194.
3
Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.炎症性和非炎症性神经系统疾病脑脊液中的游离κ轻链
Brain Sci. 2022 Apr 3;12(4):475. doi: 10.3390/brainsci12040475.
4
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.κ 游离轻链在多发性硬化症诊断中的作用日益增加。
Cells. 2021 Nov 6;10(11):3056. doi: 10.3390/cells10113056.
5
Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.κ 轻链在脑脊液中的应用作为多发性硬化症诊断的生物标志物:诊断算法的开发。
Clin Chem Lab Med. 2018 Mar 28;56(4):609-613. doi: 10.1515/cclm-2017-0285.
6
Intrathecal kappa free light chains as markers for multiple sclerosis.鞘内κ 游离轻链作为多发性硬化症的标志物。
Sci Rep. 2020 Nov 23;10(1):20329. doi: 10.1038/s41598-020-77029-7.
7
CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.脑脊液游离轻链作为多发性硬化症鞘内免疫球蛋白合成的标志物:一项大样本队列中血-脑脊液屏障相关评估。
Front Immunol. 2019 Mar 29;10:641. doi: 10.3389/fimmu.2019.00641. eCollection 2019.
8
Kappa Free Light Chains in Cerebrospinal Fluid of Patients with Identified Oligoclonal Immunoglobulin G.已鉴定出寡克隆免疫球蛋白G的患者脑脊液中的游离κ轻链
Psychiatr Danub. 2017 May;29(Suppl 2):124-128.
9
Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams.脑脊液游离轻链的诊断相关性——在商图中进行可靠数据解读的双曲线参考范围。
Clin Chim Acta. 2019 Oct;497:153-162. doi: 10.1016/j.cca.2019.07.027. Epub 2019 Jul 25.
10
The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation.免疫调节治疗对神经炎症中κ 轻链作为生物标志物的影响。
Cells. 2020 Mar 31;9(4):842. doi: 10.3390/cells9040842.

引用本文的文献

1
Kappa free light chain concentration in serum is reduced after CD20-depletion with ocrelizumab.使用奥瑞珠单抗清除CD20后,血清中的κ游离轻链浓度降低。
Neurol Res Pract. 2025 Aug 22;7(1):58. doi: 10.1186/s42466-025-00419-7.
2
Pilot study of cerebrospinal fluid biomarkers reveals inflammatory changes in patients with paranoid schizophrenia.脑脊液生物标志物的初步研究揭示了偏执型精神分裂症患者的炎症变化。
Sci Rep. 2025 Aug 3;15(1):28319. doi: 10.1038/s41598-025-13367-8.
3
Kappa Free Light Chain Index Correlates With Prognostic Biomarkers in Multiple Sclerosis and Decreases Slowly Following Treatment.

本文引用的文献

1
Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases.寡克隆带的证据并不能排除非炎性神经系统疾病。
Diagnostics (Basel). 2020 Dec 28;11(1):37. doi: 10.3390/diagnostics11010037.
2
Intrathecal kappa free light chains as markers for multiple sclerosis.鞘内κ 游离轻链作为多发性硬化症的标志物。
Sci Rep. 2020 Nov 23;10(1):20329. doi: 10.1038/s41598-020-77029-7.
3
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders.κ指数与脑脊液寡克隆区带在预测多发性硬化症及感染性/炎症性中枢神经系统疾病中的比较
κ游离轻链指数与多发性硬化症的预后生物标志物相关,且治疗后下降缓慢。
Eur J Neurol. 2025 Jul;32(7):e70291. doi: 10.1111/ene.70291.
4
The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis.游离κ轻链指数与中央静脉征:多发性硬化诊断的两种新生物标志物。
Neurol Ther. 2025 Jun;14(3):711-731. doi: 10.1007/s40120-025-00737-7. Epub 2025 Apr 6.
5
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.确定κ 游离轻链指数和寡克隆带的最佳组合,以准确诊断多发性硬化症。
Front Immunol. 2023 Oct 25;14:1288169. doi: 10.3389/fimmu.2023.1288169. eCollection 2023.
6
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.卡帕游离轻链生物标志物对多发性硬化症的诊断具有较高的效能:一项大型多中心队列研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 14;10(1). doi: 10.1212/NXI.0000000000200049. Print 2023 Jan.
7
The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis.用κ 游离轻链诊断多发性硬化症。
Medicina (Kaunas). 2022 Oct 24;58(11):1512. doi: 10.3390/medicina58111512.
8
Saliva Free Light Chains in Patients with Neuro-Sjögren.神经干燥综合征患者的唾液游离轻链
Biomedicines. 2022 Oct 3;10(10):2470. doi: 10.3390/biomedicines10102470.
9
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis.早发型和晚发型多发性硬化症中的诊断性脑脊液生物标志物
Biomedicines. 2022 Jul 7;10(7):1629. doi: 10.3390/biomedicines10071629.
10
Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements.脑脊液和血清游离轻链κ检测的实验室间一致性。
Biomolecules. 2022 May 7;12(5):677. doi: 10.3390/biom12050677.
Diagnostics (Basel). 2020 Oct 21;10(10):856. doi: 10.3390/diagnostics10100856.
4
Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy.游离轻链 κ 可区分脊髓炎和非炎症性脊髓病。
Neurol Neuroimmunol Neuroinflamm. 2020 Sep 18;7(6). doi: 10.1212/NXI.0000000000000892. Print 2020 Nov.
5
Free light chain kappa and the polyspecific immune response in MS and CIS - Application of the hyperbolic reference range for most reliable data interpretation.游离轻链κ与多发性硬化症和临床孤立综合征中的多特异性免疫反应——双曲线参考范围在最可靠数据解读中的应用
J Neuroimmunol. 2020 Jun 12;346:577287. doi: 10.1016/j.jneuroim.2020.577287.
6
Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.鞘内游离轻链kappa 与 OCB 对 MS 的诊断准确性比较。
Neurol Neuroimmunol Neuroinflamm. 2020 Jun 11;7(4). doi: 10.1212/NXI.0000000000000775. Print 2020 Jul.
7
Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing.免疫固定电泳仅检出单条区带患者κ 游离轻链的诊断价值。
Clin Chim Acta. 2020 Aug;507:205-209. doi: 10.1016/j.cca.2020.04.029. Epub 2020 Apr 27.
8
Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?游离κ轻链的赖伯图:评估鞘内合成的新标准?
Diagnostics (Basel). 2019 Nov 16;9(4):194. doi: 10.3390/diagnostics9040194.
9
Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams.脑脊液游离轻链的诊断相关性——在商图中进行可靠数据解读的双曲线参考范围。
Clin Chim Acta. 2019 Oct;497:153-162. doi: 10.1016/j.cca.2019.07.027. Epub 2019 Jul 25.
10
Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.脑脊液游离轻链。不同方法检测鞘内合成的比较。
Clin Chem Lab Med. 2019 Sep 25;57(10):1574-1586. doi: 10.1515/cclm-2018-1300.